Bristol-Myers Squibb moving 90 manufacturing jobs from New York facility

Bristol-Myers Squibb building
The action reduces the number of employees at the Dewitt plant to 410 from the 503 it employed last year. (Bristol-Myers Squibb)

Bristol-Myers Squibb will move about 90 manufacturing jobs from its DeWitt, New York, facility to plants in Massachusetts and New Jersey.

The changes are part of the company’s restructuring efforts, Pharmafile reported.

Lisa McCormick Lavery, the company’s director of corporate communications, told the publication that the moves are part of a plan to consolidate related positions within the company that includes transferring other positions from company facilities in Connecticut, Indiana and Seattle to the same two sites.

Whitepaper

Simplify and Accelerate Drug R&D With the MarkLogic Data Hub Service for Pharma R&D

Researchers are often unable to access the information they need. And, even when data does get consolidated, researchers find it difficult to sift through it all and make sense of it in order to confidently draw the right conclusions and share the right results. Discover how to quickly and easily find, synthesize, and share information—accelerating and improving R&D.

The action reduces the number of employees at the Dewitt plant to 410 from the 503 it employed last year. 

The change is expected to be completed by first-quarter 2019; however, they are not expected to have an effect on manufacturing operations at the DeWitt facility.

Suggested Articles

Higher operating costs were behind a 17% slide in pretax profits last year at Allergan’s Mayo, Ireland, facility that produces Botox.

After a global scare over Zantac contamination, generic metformin could be next in line as regulators test for possible carcinogen contamination.

PCI Pharma Services debuts expansion of its plant in Rockford, Illinois.